Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Dominica Health Times.
Press releases published on April 2, 2025
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
GlobeNewswire
·
April 2, 2025
Damien McDonald appointed CEO, effective as of May 12, 2025 Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “The Company”) (NYSE: ENOV), a leader in …
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
GlobeNewswire
·
April 2, 2025
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein (a-syn) antibody levels on average over 20-fold …
Former EPA Flint Emergency Coordinator Expands Groundbreaking Drinking Water Training Program
GlobeNewswire
·
April 2, 2025
CHICAGO, April 02, 2025 (GLOBE NEWSWIRE) -- Environmental …
The Ensign Group Adds Two Operations in California
GlobeNewswire
·
April 2, 2025
SAN JUAN CAPISTRANO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …
The Ensign Group Purchases Two Facilities in Washington
GlobeNewswire
·
April 2, 2025
SAN JUAN CAPISTRANO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
GlobeNewswire
·
April 2, 2025
STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
Global NK Cell Therapy Clinical Trials FDA Approval Patent Market Size Report 2025
GlobeNewswire
·
April 2, 2025
Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations and Market Opportunity Insight 2025 Report Highlights and Findings: Global …
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
GlobeNewswire
·
April 2, 2025
Lugano, Switzerland – April 2, 2025 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of nearly fifty years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, today announced the …
AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)
GlobeNewswire
·
April 2, 2025
CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemia Final European Commission decision expected by June 2025; UK regulatory submission foreseen via …
ENA Respiratory Announces Publication Supporting the Potential of its Novel Intranasal Therapy INNA-051 to Reduce the Impact of Viral Respiratory Infections in Older Adults
GlobeNewswire
·
April 2, 2025
Clinical studies demonstrated that INNA-051’s natural defence boosting mechanism is effective in older adults Administration of INNA-051 to older adults (65 years old) in a Phase 1 study was well-tolerated and increased important antiviral host-defence …
CMR Surgical secures more than $200M to accelerate growth
GlobeNewswire
·
April 2, 2025
CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital The latest funding will fuel the global commercialisation of its Versius Surgical Robotic System, particularly in the U.S. …
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay
GlobeNewswire
·
April 2, 2025
PRESS RELEASE 02/04/2025, 07:00 CEST Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay Mechelen, Belgium, 02 April 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce the launch …
Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.
GlobeNewswire
·
April 2, 2025
ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m Pentetate Injection, often referred to as DTPA ( …
Gluco6 Review Exposed (SHOCKING FINDINGS): Why Doctors Are Calling This the Glucose Game-Changer
GlobeNewswire
·
April 2, 2025
JUPITER, FL, April 02, 2025 (GLOBE NEWSWIRE) -- Gluco6 If you’ve been battling unstable blood sugar, low energy, relentless sugar cravings, or that creeping weight gain that won’t budge — you’re not alone. Millions are searching for a way to support …
Endoscopic Ultrasonography Market to Hit US$1.93 Billion by 2029 with 7.1% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 2, 2025
Delray Beach, FL, April 01, 2025 (GLOBE NEWSWIRE) -- The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$1.37 billion in 2024 and an impressive US$1.93 billion by 2029 …